Tag Archives: Dessislava Fessenko
Benefits & Risks of Using Anonymized Health Data in Research
Dessislava Fessenko discusses some of the ethical challenges of access to and use of anonymized health data and how risks and benefits to society could be balanced.
Genetic Selection for Non-Disease Traits
Dessislava Fessenko discusses the moral permissibility of genetic selection for non-disease traits and highlights some of the ultimate considerations that should define it.
Mind the Ethical Gap in AI-Powered Drug Discovery
Dessislava Fessenko shows that while artificial intelligence might revolutionize drug development, its use comes with risks and potential ethical implications. Iterative ethics oversight from the get-go is needed to address the looming concerns.
Whose Responsibility Are Ethical Issues in Phase 1 Research?
Dessislava Fessenko reveals that ethical concerns surrounding the participation of healthy volunteers in Phase 1 clinical trials have deep roots in broader social conditions, which require social policy responses.
Impact Ethics 